Joel Troop, MD
Orthopaedic Surgery · Ardmore, OKNPI 1043274798
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,808 of the $6,223 with a category attached, or 77.3%. Pylant Medical accounts for 77.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $2,743 and has fallen 92.3% since, to $211 in 2025.
Across 77 payments — averaging $80.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$5K
- Pacira Therapeutics, Inc.$320
- Johnson & Johnson$206
- Pacira Pharmaceuticals Incorporated$124
- Stryker$87
- Ferring Pharmaceuticals Inc.$60
- plus $586 from 21 others
What the payments were for
- Food & beverage$1,41523%
- Education$4,80877%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 7 | $4,839 |
| Pacira Therapeutics, Inc. | 17 | $320 |
| Johnson & Johnson | 11 | $206 |
| Pacira Pharmaceuticals Incorporated | 6 | $124 |
| Stryker | 2 | $87 |
| Ferring Pharmaceuticals Inc. | 4 | $60 |
| Orthalign Inc | 1 | $55 |
| Nevro Corp. | 2 | $50 |
| Spinal Simplicity, LLC | 1 | $45 |
| Bioventus LLC | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| SPR Therapeutics, Inc | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Curonix LLC | 1 | $29 |
| Vertex | 1 | $28 |
| Naviswiss, Inc. | 1 | $28 |
| Omnilife Science, Inc | 2 | $22 |
| Organogenesis Inc. | 1 | $21 |
| Fidia Pharma USA Inc. | 3 | $21 |
| Globus Medical | 1 | $20 |
| Virtus Pharmaceuticals LLC | 1 | $19 |
| Innovation Technologies Inc | 1 | $19 |
| Avanos Medical | 1 | $16 |
| Medtronic | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$6,223 in reported general payments places this provider in the 60th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 342 | $1,977 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 94 | $544 |
| Cyclobenzaprine Hcl | 18 | $389 |
| Oxycodone Hcl | 67 | $262 |
| Meloxicam | 100 | $206 |
| Tranexamic Acid | 20 | $177 |
| Penicillin V Potassium | 32 | $37 |
| Tramadol Hcl | 26 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Ardmore
- Yogesh MittalTulsa$6.6M
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Vytautas RingusNorman$272K
- Jason EmersonOklahoma City$189K
- Brian ChalkinTulsa$183K
- Ronald DumiganOklahoma City$169K
- Kasra AhmadiniaTulsa$138K
- Sarat KunapuliTulsa$136K
- Charles WoodEdmond$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.